DrugsControl Media Services
DrugsControl.org

News Detail

Cardiac drug's patent off, domestic firms offer cheaper version (19-01-2023)

MUMBAI, 19 JAN 2023: People suffering from cardiac problems can look forward to substantial savings in their healthcare budget. Several domestic companies including Glenmark and Lupin have launched generic versions of blockbuster cardiology drug Valsartan at a fraction of the pri......
View Details

Source : The Times of India
cardiac problems domestic companies Valsartan Cidmus Azmarda

Related News